» Articles » PMID: 29321808

ITRAQ-based Proteomic Analysis to Identify the Molecular Mechanism of Zhibai Dihuang Granule in the Yin-deficiency-heat Syndrome Rats

Overview
Journal Chin Med
Publisher Biomed Central
Date 2018 Jan 12
PMID 29321808
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Zhibai Dihuang Granule (ZDG) is a traditional Chinese medicine which has been used to treat Yin-deficiency-heat (YDH) syndrome for thousands of years in China. However, little work has been conducted to explore the molecular mechanism of ZDG in YDH syndrome, and the processes of YDH syndrome prevention and treatment have been developed slowly. The present study was aimed to explore the therapeutic mechanism of ZDG on YDH syndrome.

Methods: The YDH syndrome rats were induced by hot Chinese herbs, then treated by ZDG orally for 1 week. Body weight was measured every 2 days. After sacrifice, blood samples were collected and the thymus, adrenal glands, spleen, and liver were immediately removed and weighed. iTRAQ-based proteomics approach was applied to explore the serum protein alterations with the treatment of ZDG, and to investigate the underlying mechanism of ZDG in treating YDH syndrome.

Results: The body weights of YDH syndrome rats were significantly decreased compared with control group, and increased in ZDG treated rats. The relative weights of thymus in YDH syndrome rats were increased compared with the control rats, and significantly decreased in after ZDG treatment. In the proteomic analyses, seventy-one proteins were differentially expressed in the YDH syndrome group and the ZDG treated group, including 10 up-regulated and 61 down-regulated proteins. Gene ontology analysis revealed that the differentially expressed proteins were mostly related to immune response, and pathway enrichment analysis showed that these proteins were enriched in coagulation and complement cascades. Enzyme-linked immunosorbent assay was performed to detect the protein levels in coagulation and complement cascades, and the results showed that complement component 5 levels were significantly increased, while fibrinogen gamma chain levels were significantly decreased in the ZDG treated group.

Conclusions: We found that ZDG treatment could lead to proteins alteration in immune response, especially in coagulation and complement cascades. ZDG can up-regulate the proteins in the complement cascade to eliminate pathogens, and down-regulate the proteins in the coagulation cascade to suppress inflammation. Our study provides experimental basis to understand the therapeutic mechanism of ZDG and revealed that ZDG can regulate coagulation and complement cascades in treating YDH syndrome.

Citing Articles

Traditional Chinese Medicine Decoctions Improve Longevity Following Diagnosis with Stage IV Esophageal Squamous Cell Carcinoma: A Retrospective Analysis.

Li H, Ma C, Chang S, Xi Y, Shao S, Chen M Int J Gen Med. 2022; 15:1665-1675.

PMID: 35210836 PMC: 8858954. DOI: 10.2147/IJGM.S346536.


Thrombospondin-1, Platelet Factor 4, and Galectin-1 Are Associated with Engraftment in Patients with Sickle Cell Disease who Underwent Haploidentical Hematopoietic Stem Cell Transplantation.

Shaikh A, Olkhanud P, Gangaplara A, Kone A, Patel S, Gucek M Transplant Cell Ther. 2022; 28(5):249.e1-249.e13.

PMID: 35131485 PMC: 9176382. DOI: 10.1016/j.jtct.2022.01.027.


Serum Extracellular Vesicle-Derived miR-124-3p as a Diagnostic and Predictive Marker for Early-Stage Acute Ischemic Stroke.

Qi Z, Zhao Y, Su Y, Cao B, Yang J, Xing Q Front Mol Biosci. 2021; 8:685088.

PMID: 34277703 PMC: 8280338. DOI: 10.3389/fmolb.2021.685088.


Proteomic Analysis of Rhesus Macaque Brain Explants Treated With Identifies Host GAP-43 as a Potential Factor Associated With Lyme Neuroborreliosis.

Li L, Luo L, Chen T, Cao W, Xu X, Zhang Y Front Cell Infect Microbiol. 2021; 11:647662.

PMID: 34178719 PMC: 8224226. DOI: 10.3389/fcimb.2021.647662.


Exploring the Mechanism of Zhibai Dihuang Decoction in the Treatment of Ureaplasma Urealyticum-Induced Orchitis Based on Integrated Pharmacology.

Bin D, Zhang S, Zhan M, Li L, Li Y, Zhou X Front Pharmacol. 2021; 12:602543.

PMID: 34040514 PMC: 8141734. DOI: 10.3389/fphar.2021.602543.


References
1.
MULLER-EBERHARD H, Polley M, Calcott M . Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement. J Exp Med. 1967; 125(2):359-80. PMC: 2138355. DOI: 10.1084/jem.125.2.359. View

2.
Kanwar Y, Wada J, Sun L, Xie P, Wallner E, Chen S . Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med (Maywood). 2007; 233(1):4-11. DOI: 10.3181/0705-MR-134. View

3.
Arlaud G, Gaboriaud C, Thielens N, Rossi V, Bersch B, Hernandez J . Structural biology of C1: dissection of a complex molecular machinery. Immunol Rev. 2001; 180:136-45. DOI: 10.1034/j.1600-065x.2001.1800112.x. View

4.
Saenko E, Shima M, Sarafanov A . Role of activation of the coagulation factor VIII in interaction with vWf, phospholipid, and functioning within the factor Xase complex. Trends Cardiovasc Med. 2000; 9(7):185-92. DOI: 10.1016/s1050-1738(00)00019-0. View

5.
Triantafilou K, Hughes T, Triantafilou M, Morgan B . The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation. J Cell Sci. 2013; 126(Pt 13):2903-13. DOI: 10.1242/jcs.124388. View